$591.29

-0.35%

MEDP

Medpace Holdings, Inc.

•Healthcare

Clinical Research

Biotech Outsourcing

High ROIC

Overbought

Clinical Research

Biotech Outsourcing

High ROIC

Overbought

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

2/10

Quality

10/10

Growth

8/10

Strength

5/10

Dividend

1/10

Similar Stocks

ICLR ICON plc

FTRE Fortrea Holdings Inc.

CERT Certara, Inc.

IQV IQVIA Holdings, Inc.

LH Labcorp Holdings Inc.

Health Indicators

Price Trend

Upwards

Momentum

Neutral

Balance Sheet

Healthy

Earnings

Growth

Dividend Yield

0.00%

Market Cap

$16.50B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Medpace manages clinical trials for pharmaceutical and biotechnology companies. They handle the complex logistics of testing new drugs in human patients to help get them approved by regulators. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...